| __timestamp | Amneal Pharmaceuticals, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 111110000 |
| Thursday, January 1, 2015 | 367054000 | 129714000 |
| Friday, January 1, 2016 | 420770000 | 139574000 |
| Sunday, January 1, 2017 | 507476000 | 218502000 |
| Monday, January 1, 2018 | 946588000 | 322876000 |
| Tuesday, January 1, 2019 | 1273376000 | 427320000 |
| Wednesday, January 1, 2020 | 1364130000 | 523667000 |
| Friday, January 1, 2021 | 1324696000 | 1629000 |
| Saturday, January 1, 2022 | 1427596000 | 12079000 |
| Sunday, January 1, 2023 | 1573042000 | 35989000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, understanding cost structures is pivotal. From 2014 to 2023, Amneal Pharmaceuticals, Inc. and Galapagos NV have showcased contrasting expense trajectories. Amneal's cost of revenue surged by approximately 368%, peaking in 2023, reflecting its aggressive market expansion and production scaling. In contrast, Galapagos NV experienced a volatile cost pattern, with a notable 93% drop from its 2020 peak to 2023, possibly indicating strategic shifts or operational efficiencies.
Amneal's consistent upward trend underscores its robust growth strategy, while Galapagos' fluctuating costs may suggest a focus on innovation and R&D optimization. This decade-long analysis offers a window into the strategic priorities of these pharmaceutical giants, highlighting the diverse paths companies take in balancing growth and cost management.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Galapagos NV
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for GSK plc and Galapagos NV
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Galapagos NV
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Galapagos NV
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Galapagos NV
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.